Brian Millham - Jun 20, 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)

Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Stock symbol
CRM
Transactions as of
Jun 20, 2023
Transactions value $
-$6,834,405
Form type
4
Date filed
6/21/2023, 05:08 PM
Previous filing
Apr 24, 2023
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $2.48M +15.4K +111.54% $161.50 29.1K Jun 20, 2023 Direct F1
transaction CRM Common Stock Options Exercise $970K +8.22K +28.21% $118.04 37.4K Jun 20, 2023 Direct F1
transaction CRM Common Stock Options Exercise $971K +6.61K +17.69% $146.87 44K Jun 20, 2023 Direct F1
transaction CRM Common Stock Options Exercise $5.38M +34.9K +79.41% $154.14 78.9K Jun 20, 2023 Direct F1
transaction CRM Common Stock Sale -$2.69M -12.9K -16.33% $208.92 66K Jun 20, 2023 Direct F1, F2
transaction CRM Common Stock Sale -$2.59M -12.3K -18.69% $210.09 53.7K Jun 20, 2023 Direct F1, F3
transaction CRM Common Stock Sale -$3.76M -17.8K -33.19% $211.24 35.8K Jun 20, 2023 Direct F1, F4
transaction CRM Common Stock Sale -$3.67M -17.3K -48.21% $212.20 18.6K Jun 20, 2023 Direct F1, F5
transaction CRM Common Stock Sale -$1.02M -4.79K -25.81% $212.90 13.8K Jun 20, 2023 Direct F1, F6
transaction CRM Common Stock Sale -$598K -2.86K -20.77% $208.96 10.9K Jun 20, 2023 Direct F1, F7
transaction CRM Common Stock Sale -$525K -2.5K -22.91% $210.11 8.41K Jun 20, 2023 Direct F1, F8
transaction CRM Common Stock Sale -$779K -3.69K -43.85% $211.23 4.72K Jun 20, 2023 Direct F1, F9
transaction CRM Common Stock Sale -$691K -3.26K -68.99% $212.11 1.47K Jun 20, 2023 Direct F1, F10
transaction CRM Common Stock Sale -$312K -1.47K -100% $212.86 0 Jun 20, 2023 Direct F1, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -15.4K -100% $0.00* 0 Jun 20, 2023 Common Stock 15.4K $161.50 Direct F1, F12
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -8.22K -100% $0.00* 0 Jun 20, 2023 Common Stock 8.22K $118.04 Direct F1, F13
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -6.61K -100% $0.00* 0 Jun 20, 2023 Common Stock 6.61K $146.87 Direct F1, F14
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -34.9K -64.51% $0.00 19.2K Jun 20, 2023 Common Stock 34.9K $154.14 Direct F1, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2023.
F2 Weighted average price. These shares were sold in multiple transactions at prices ranging from $208.6500 to $209.5600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $209.6600 to $210.5800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $210.6600 to $211.6500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $211.8000 to $212.7700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Weighted average price. These shares were sold in multiple transactions at prices ranging from $212.8000 to $213.1200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 Weighted average price. These shares were sold in multiple transactions at prices ranging from $208.6500 to $209.4900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 Weighted average price. These shares were sold in multiple transactions at prices ranging from $209.6600 to $210.5800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F9 Weighted average price. These shares were sold in multiple transactions at prices ranging from $210.6600 to $211.6500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F10 Weighted average price. These shares were sold in multiple transactions at prices ranging from $211.7000 to $212.6700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F11 Weighted average price. These shares were sold in multiple transactions at prices ranging from $212.7500 to $213.1200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F12 Option is exercisable and vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F13 Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F14 Option is exercisable and vests over four years at the rate of 25% on July 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F15 Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.